Shareholders’ Equity - Schedule of Warrants Activity (Details) - Warrant - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of warrants outstanding, beginning balance (in shares)	565,544
Granted (in shares)	166,667
Exercised (in shares)	(540,541)
Expired (in shares)	(25,000)
Number of warrants outstanding, ending balance (in shares)	166,670	565,544
Weighted Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share)	$ 9.96
Granted (in usd per share)	15.00
Exercised (in usd per share)	9.25
Expired (in usd per share)	9.25
Weighted average exercise price, ending balance (in dollars per share)	$ 17.40	$ 9.96
Share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, outstanding	$ 0	$ 3,546
Weighted average remaining contractual life (in years)	9 years 7 months 6 days	1 month 6 days
Weighted average remaining contractual life, granted (in years)		9 years 9 months 18 days